about
Hepatitis E Virus Mutations: Functional and Clinical RelevanceHepatitis E in Germany--an under-reported infectious diseaseIn vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracilLow level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam.Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman.Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in Vietnamese patients.High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.Molecular pathology of inflammatory cardiomyopathy.Janus kinase 3 regulates renal 25-hydroxyvitamin D 1α-hydroxylase expression, calcitriol formation, and phosphate metabolism.Infection with the Persistent Murine Norovirus Strain MNV-S99 Suppresses IFN-Beta Release and Activation of Stat1 In Vitro.Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria.Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.Detection and genome characterization of four novel bat hepadnaviruses and a hepevirus in China.Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.Parvovirus B19 infection mimicking acute myocardial infarction.Genetic insights on host and hepatitis B virus in liver diseases.Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line.Application of modified antisense oligonucleotides and siRNAs as antiviral drugs.Hepatitis B virus DNA quantification with the three-in-one (3io) method allows accurate single-step differentiation of total HBV DNA and cccDNA in biopsy-size liver samples.Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication.Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus.Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants.The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro.In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection.Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver.Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus.Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma.Inhibition of Na+/H+ exchanger activity by parvovirus B19 protein NS1.Group A Rotaviruses circulating prior to a National Immunization Programme in Nigeria: clinical manifestations, high G12P[8] frequency, intra-genotypic divergence of VP4 and VP7.Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis.Identification of a Novel Hepatitis E Virus Genotype 3 Strain Isolated from a Chronic Hepatitis E Virus Infection in a Kidney Transplant Recipient in Switzerland.Heteroduplex between an EMBL3 genomic clone and a lambda gt11 cDNA clone provides internal size standards.Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.Variation of human mucin gene expression in gastric cancer cell lines and gastric mucous cell primary cultures.Up-regulation of epithelial Na(+) channel ENaC by human parvovirus B19 capsid protein VP1.Use of sequence analysis of the P2 domain for characterization of norovirus strains causing a large multistate outbreak of norovirus gastroenteritis in Germany 2012.Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics
P50
Q26741356-87676D34-4511-4CE4-B379-B8D44C640433Q27002938-8CCFA4E5-AA4E-43A4-BB58-C32356870216Q28345952-F93D9BC4-B814-4310-9BA3-17EAD6A87361Q30318661-C7FDC674-527D-4270-A3D8-DA45C7B321ACQ33558023-355608B9-0924-4413-A128-5A845242359AQ33623694-979549AD-2C03-46E2-83A5-F4D0BCED6496Q34091258-65F2FC3D-25C4-4CF4-9B2D-1FDAEACEE1AEQ34554896-55165454-0FFD-4948-B192-949B41308F45Q35200629-2B8A7BF4-CE30-4561-A09B-C54D41057FB7Q35507681-F6BB0539-9041-4DF0-9AE8-EF36FC8262EBQ36050362-C4D1B9BD-0E8D-4695-8D2A-878834340837Q36326300-05458CC0-FDE0-4CD2-AE0D-A072C88BA8BCQ36765645-1F3CAAFF-AED1-4CC7-B254-8E883C82595CQ36845694-A3ACFE9A-8B23-40EB-B812-76A04315CCC4Q37658397-BD07A822-5CCC-452E-9025-30A561B579FDQ37792970-B93757B0-F4BF-496D-A429-4B56CF7BC44FQ37868780-59AC864F-7E30-452E-A6AF-DBEF92FD05A7Q38283175-E499C59E-4162-4668-ABA4-8B8E97CA915EQ38773125-CF13AE09-0183-4D5C-9EA9-4C0F83DD773AQ38962711-14357D5C-6622-4734-9BDF-268E93501DA5Q38988909-51E35436-BF9A-43FA-9386-0081C54D8195Q39139230-B4BDB514-4EFA-4F2E-BAE7-39142DA1B4A4Q39478545-751CCE72-43E9-4890-8912-CDC0505BBA27Q39528976-4CF10E0E-23C1-4360-89FF-C0BB7AE66EF4Q39589532-7B4507B4-5D9F-430F-823B-461F2DC65410Q39737884-5AF44DC8-A73B-49BD-84C3-9B97C152C015Q39738999-12E723A5-3AA8-4043-A746-48974AFEE267Q39764153-C60594F8-0479-4598-B848-E73DA9BD935EQ39794252-3842395F-0B5A-43DC-AC18-F299DFC7FF69Q39868194-C731DB79-2746-432B-9610-D017B6457C6CQ39877840-5F7914FE-0047-46BC-9380-E136EE533242Q40041680-9A7C04EE-834E-4A43-8D9D-08A4EBA72B78Q40130961-C414A1C5-7B6C-4213-845F-FB5433B66E45Q40195807-76B3547D-019F-4D23-A375-3A63DE6FE168Q40522841-41431FA7-92D4-4BF0-B92B-51E2A503D426Q40712244-20D0E8BF-9DF9-4185-B005-32D92EF4E707Q40911074-EDF2E73C-87EE-44EE-93BA-16B339BD4304Q40928133-1FD9A587-FEF0-49EB-88C8-7B51C942EB89Q41014930-F9133F79-B3E3-4FD6-BE2B-A0588C931809Q41015358-757268DC-9ABE-4536-920B-31C2F7923052
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thomas C Bock
@ast
Thomas C Bock
@en
Thomas C Bock
@es
Thomas C Bock
@nl
Thomas C Bock
@sl
type
label
Thomas C Bock
@ast
Thomas C Bock
@en
Thomas C Bock
@es
Thomas C Bock
@nl
Thomas C Bock
@sl
prefLabel
Thomas C Bock
@ast
Thomas C Bock
@en
Thomas C Bock
@es
Thomas C Bock
@nl
Thomas C Bock
@sl
P106
P21
P31
P496
0000-0002-2773-486X